Pricing Log in Create free account

Bristol Myers Squibb Company (BMY) vs Sanofi (SNY)

Bristol Myers Squibb Company and Sanofi are both Drug Manufacturers General companies. Bristol Myers Squibb Company is the larger, with a market value of $129.0B against $111.8B — 1.2× the size. Bristol Myers Squibb Company trades at the lower P/E: 13.7× against 23.3×. Sanofi grew revenue faster over the last twelve months: 26.3% against 4.16%. Bristol Myers Squibb Company has the higher net margin (18.5% vs 8.27%) and the higher return on invested capital (13.2% vs 7.05%). Both pay a dividend; Sanofi yields more (5.15% vs 4.06%). Across the 23 metrics below, Sanofi leads on 12 and Bristol Myers Squibb Company on 11.

Valuation

Metric BMY SNY Drug Manufacturers General median
P/E 13.75 23.30 26.51
P/S 2.54 1.91 3.49
P/B 5.42 1.40 5.28
Price to free cash flow 13.67 6.75 21.67
EV/EBITDA 11.13 11.45 14.73
EV/Sales 3.14 2.14 4.15
Earnings yield 7.27% 4.29% 2.41%
Free cash flow yield 7.32% 14.82% 4.07%

Profitability

Metric BMY SNY Drug Manufacturers General median
Gross margin 69.24% 73.44% 73.01%
Operating margin 22.65% 18.73% 18.34%
Net margin 18.47% 8.27% 7.31%
Free cash flow margin 18.56% 40.26% 18.56%
Return on equity 44.01% 0.00% 5.80%
Return on assets 9.96% 3.24% 2.28%
Return on invested capital 13.19% 7.05% 6.26%

Growth

Metric BMY SNY Drug Manufacturers General median
Revenue growth (TTM) 4.16% 26.32% 6.72%
EPS growth (last fiscal year) 178.46% 45.97% 21.81%
Revenue growth, 5-year CAGR 2.54% 4.37% 4.75%
Net income growth, 5-year CAGR 0.00% (8.87%) 0.00%

Health

Metric BMY SNY Drug Manufacturers General median
Debt to equity 1.83 0.25 0.62
Current ratio 1.59 1.12 1.39
Net debt to EBITDA 2.58 0.76 1.15

Dividend

Metric BMY SNY Drug Manufacturers General median
Dividend yield 4.06% 5.15% 2.32%
Payout ratio 0.56 1.20 0.59

Size

Metric BMY SNY Drug Manufacturers General median
Market cap 129.04b 111.81b 129.04b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack